Allegria Therapeutics

BiotechnologySeedBasel, Switzerlandallegriatx.com

Latest round

Seed

Last raised

Dec 2025

Total raised

$8.6M

Investors

4

About Allegria Therapeutics

Founded in 2023 and based in Switzerland, by Co-founder and CEO Maria Van Dongen, Allegria Therapeutics operates as a biotechnology research company that develops biopharmaceuticals for treating allergies and mast cell-mediated diseases. The firm develops and offers proprietary therapeutic approaches for mast cell-mediated diseases. Mast cells play a crucial role in allergy and inflammatory conditions. The company generates revenue from providing biotech research services and engaging in R&D collaborations focused on mast cell diseases.

Who invested in Allegria Therapeutics

4 investors across 2 rounds

See all investors in Allegria Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Dec 3, 2025

    Amount

    $5.1M

    Investors

    Locked

  2. Seed

    May 6, 2024

    Amount

    $3.5M

    Investors

    Locked

Questions about Allegria Therapeutics

Who invested in Allegria Therapeutics?

Allegria Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Allegria Therapeutics raised?

Allegria Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Allegria Therapeutics last raise money?

Allegria Therapeutics's most recent round on record is a Seed, in Dec 2025.

What does Allegria Therapeutics do?

Founded in 2023 and based in Switzerland, by Co-founder and CEO Maria Van Dongen, Allegria Therapeutics operates as a biotechnology research company that develops biopharmaceuticals for treating allergies and mast cell-mediated diseases.

Where is Allegria Therapeutics headquartered?

Allegria Therapeutics is headquartered in Basel, Switzerland.

Which VCs invest in companies like Allegria Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Allegria Therapeutics's stage. Their profiles are linked below.

Raising like Allegria Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.